Melina Marmarelis

Medical Director of Penn Medicine Mesothelioma and Pleural Program, University of Pennsylvania

Co-Director, Molecular Tumor Board at the University of Pennsylvania

Melina Marmarelis, MD, MSCE, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I), Assistant Professor at the University of Pennsylvania, Medical Director of the Penn Medicine Mesothelioma and Pleural Disease Program, and Co-Director of the Molecular Tumor Board at the University of Pennsylvania. She specializes in thoracic medical oncology. Her research focuses on early phase clinical trials in lung cancer and mesothelioma, determinants of therapy resistance and sensitivity, and molecular characteristics and testing in non-small cell lung cancer (NSCLC).

Dr. Marmarelis earned her medical degree at Harvard Medical School. She completed her residency at Brigham and Women’s Hospital and Hematology/Oncology fellowship at the Hospital of the University of Pennsylvania. Dr. Marmarelis is board certified in internal medicine and medical oncology.

Melina’s Work

iNUDGE: Integration of Liquid Biopsy Based Next Generation Gene Sequencing in Newly Diagnosed NSCLC

• Behavior Change
• Clinical Transformation

Optimizing Biomarker Detection and Extending Life for Patients with Non-Small Cell Lung Cancer

• Behavior Change
• Clinical Transformation